Streetbeat News

Regulatory

SIGA

The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) announced that SIGA Technologies' antiviral tecovirimat did not meet its primary endpoint in a study for treating monkeypox virus in the Democratic Republic of the Congo. The study showed no statistically significant improvement in lesion resolution within 28 days. SIGA's stock dropped 38.3% following the news.

Portfolio Pulse from Vandana Singh

August 15, 2024 | 1:01 pm

QNTM

Trading halt status was updated at 8:55:00 AM ET, indicating a resumption of quotations. The news and resumption times are provided.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:55 pm

GDHG

Golden Heaven Group shares are trading lower after the company received a Nasdaq Delisting notice.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:41 pm

CING

Cingulate shares are trading higher after the company was granted European patent No. 3261625 for CTx-1301, its lead asset for the treatment of ADHD.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:32 pm

GOOG

GOOGL

Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) is appealing against the DOJ's antitrust ruling to avoid a potential breakup. Analyst Ray Wang discussed the market's anticipation of the appeal and the implications of Alphabet's exclusive deals with companies like Apple. Despite the DOJ's victory, a breakup is considered unlikely by some experts.

Portfolio Pulse from Benzinga Neuro

August 15, 2024 | 12:26 pm

SIGA

SIGA Technologies shares are trading lower after the National Institutes of Health's National Institute of Allergy and Infectious Diseases announced that the PALM 007 trial of Tecovirimat for Monkeypox virus did not meet its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:14 pm

TPST

Tempest Therapeutics (TPST) announced a successful end-of-Phase 2 meeting with the FDA for Amezalpat in first-line hepatocellular carcinoma. There is broad agreement on the pivotal Phase 3 study plan, with overall survival as the primary study endpoint.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:05 pm

OTRK

Ontrak Health has secured the HITRUST CSF Certification for 2024, demonstrating its commitment to data security and compliance.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:04 pm

BTCUSD

Crypto heists have surged 84.4% in 2024, with over $1.58 billion stolen through July. Despite a decrease in overall illicit activity in the cryptocurrency ecosystem, stolen funds and ransomware attacks have increased significantly. Centralized exchanges are being targeted more, with Bitcoin representing 40% of stolen assets. The average amount stolen per incident has risen to $10.6 million. Ransomware payments have also increased, with a single payment reaching $75 million. However, victims are paying ransoms less often, indicating better preparedness. The importance of blockchain analysis and law enforcement actions in combating these threats is emphasized.

Portfolio Pulse from Murtuza Merchant

August 15, 2024 | 12:02 pm

SIGA

Trading halt status for SIGA Technologies was updated at 8:00:00 AM ET. The article provides information on the news and resumption times for the stock.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:00 pm